silybin has been researched along with carbon tetrachloride in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bartalis, J; Halaweish, FT | 1 |
Alcantar, LK; Chávez, E; Hernández, Mdel C; Moreno, MG; Muriel, P | 1 |
Chu, C; Gao, X; Tong, S; Wang, L; Wei, Y; Xu, X; Yu, J | 1 |
Baek, JY; Byun, EH; Cho, BO; Jeong, IY; Jin, CH; Park, KH; Ryu, HW; So, Y | 1 |
Feng, SL; Li, YZ; Liu, CX; Liu, L; Liu, ZQ; Xie, Y; Yuan, ZW; Zhou, H | 1 |
Bui, QD; Chi, SC; Ho, XH; Nguyen, HA; Nguyen, TD; Pham, DV; Tran, CS; Tung, NT | 1 |
Dhawan, V; Fahr, A; Lokras, A; Nagarsenker, M; Saraf, M; Sutariya, B; Thamm, J; Warawdekar, U | 1 |
Liu, X; Lu, Y; Qiu, S; Wang, M; Xing, H; Xu, R; You, M; Zhang, J; Zhang, L; Zhang, P; Zhu, J | 1 |
8 other study(ies) available for silybin and carbon tetrachloride
Article | Year |
---|---|
In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.
Topics: Animals; Cell Line; Cell Proliferation; Cucurbitacins; Fibrosis; Hep G2 Cells; Hepatic Stellate Cells; Humans; Hydrophobic and Hydrophilic Interactions; Liver; Protective Agents; Quantitative Structure-Activity Relationship; Rats | 2011 |
Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Carbon Tetrachloride; Colchicine; Collagen; Liver; Liver Cirrhosis, Experimental; Liver Glycogen; Male; Protective Agents; Rats; Rats, Wistar; Silybin; Silymarin; Time Factors | 2005 |
Preparation and effects of 2,3-dehydrosilymarin, a promising and potent antioxidant and free radical scavenger.
Topics: Animals; Carbon Tetrachloride; Chromatography, High Pressure Liquid; Free Radical Scavengers; Free Radicals; Liver; Male; Mass Spectrometry; Mice; Oxidation-Reduction; Silybin; Silymarin; Solubility | 2011 |
Hepatoprotective effect of 2,3-dehydrosilybin on carbon tetrachloride-induced liver injury in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; DNA Damage; Hep G2 Cells; Humans; Lipid Peroxidation; Liver; Male; Protective Agents; Rats; Rats, Sprague-Dawley; Silybin; Silymarin | 2013 |
Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies.
Topics: Animals; ATP-Binding Cassette Transporters; Biological Availability; Caco-2 Cells; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dogs; Flavones; Humans; Madin Darby Canine Kidney Cells; Male; Mice, Inbred C57BL; Rats, Sprague-Dawley; Silybin | 2018 |
Formulation and biopharmaceutical evaluation of supersaturatable self-nanoemulsifying drug delivery systems containing silymarin.
Topics: Animals; Biological Availability; Carbon Tetrachloride; Chemistry, Pharmaceutical; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Liberation; Emulsions; Liver Diseases; Male; Mice; Nanoparticles; Poloxamer; Protective Agents; Rabbits; Silybin; Silymarin; Solubility | 2019 |
Lipid nanoconstructs for superior hepatoprotection: In vitro assessments as predictive tool for in vivo translation.
Topics: Administration, Oral; Animals; Biological Availability; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Drug Liberation; Drug Stability; Excipients; Female; In Vitro Techniques; Lipids; Liver; Nanotechnology; Particle Size; Permeability; Rats; Silybin; Solubility; Surface Properties | 2020 |
Silibinin Schiff Base Derivatives Counteract CCl
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Liver; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; Schiff Bases; Silybin; Silymarin | 2022 |